Deprescribing and Polypharmacy in an Aging Population
Autor Ali Elbeddinien Limba Engleză Paperback – 21 aug 2023
- Emphasizes the importance of involving a multidisciplinary team in deprescribing efforts
- Identifies barriers and enablers for the implementation of deprescribing programs
- Develops strategies to address barriers and optimize enablers for deprescribing implementation
Preț: 812.96 lei
Preț vechi: 1025.42 lei
-21% Nou
Puncte Express: 1219
Preț estimativ în valută:
155.58€ • 161.61$ • 129.24£
155.58€ • 161.61$ • 129.24£
Carte tipărită la comandă
Livrare economică 27 ianuarie-10 februarie 25
Livrare express 27 decembrie 24 - 02 ianuarie 25 pentru 185.80 lei
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780323991384
ISBN-10: 0323991386
Pagini: 166
Dimensiuni: 152 x 229 x 11 mm
Greutate: 0.23 kg
Editura: ELSEVIER SCIENCE
ISBN-10: 0323991386
Pagini: 166
Dimensiuni: 152 x 229 x 11 mm
Greutate: 0.23 kg
Editura: ELSEVIER SCIENCE
Public țintă
Healthcare professionals involved in the circle of care and Pharmacy and medical school students & residents and professorsHospital leadership and Policy makers
Cuprins
1. A global overview of the current state of deprescribing 2. Health policies and deprescribing: An introduction to health policies, knowledge translation, and the barriers, challenges, and enablers to health policy implementation 3. Deprescribing is an essential part of prescribing 4. Deprescribing in school curriculums: An overview of current education standards and what should be changed 5. The role of the multidisciplinary healthcare team in deprescribing 6. Looking to the future: Artificial intelligence in enhancing patient care 7. Challenges/barriers of deprescribing during Covid-19 8. Deprescribing in pallative care and Alzheimer's patients: Optimizing medication use for improved quality of life
Recenzii
"This publication serves as an overview of important concepts in medication use, such as polypharmacy and deprescribing... [And] provide[s] an assessment of current practices, limitations, and barriers to identify polypharmacy-related drug events for healthcare providers (HCPs) practicing in global healthcare settings... useful, but specific to the impact of polypharmacy on adverse drug events and challenges to implement deprescribing. The tools and strategies presented can be used to make meaningful changes to health care curriculum and health care policy." --©Doody’s Review Service, 2024, Susan Romann, PharmD, BCGP (Temple University School of Pharmacy)